Retour
Prix Swedish Orphan Biovitrum AB (publ) (BIOVF)
Graphique du cours de l'action BIOVF
BIOVF Gagner
Swedish Orphan Biovitrum AB (publ)
$37
0%
$0
À la fermeture : Jan 16, 16:00:00 GMT-5
$37
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$37
Prix d'ouverture
$32.06
Plage de la journée
$32.06 - $37
Plage de 52 semaines
$25.79 - $37
Volume
1
Volume moyen
26
BPA (TTM)
0.00
Rendement en dividend
--
Capitalisation boursière
$12.7B
Qu’est-ce que BIOVF ?
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Stockholm, Stockholm and currently employs 1,890 full-time employees. The company went IPO on 2006-09-15. The firm develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The firm has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved